COMPARE · Data as of August 28, 2026
AGNC vs EFC
Verdict: Side-by-side breakdown using the Bull Rankings model. AGNC scored 68.0, EFC scored 65.0 — AGNC leads.
Compare another set
Different reporting periods. AGNC's fundamentals are as of June 2026, but EFC's are as of March 2026 — a 3-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
AGNC
AGNC Investment Corp.
71.7Fin
$10.94 · $13.0B
fundamentals as of
Strength gap
5.8
EFC leads
EFC
Ellington Financial Inc.
77.5Fin
$13.57 · $1.8B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- Fastest growthAGNC+84.7%
- Strongest balance sheetAGNC7.17
Side by side · every name on one set of axes
Fundamentals, head-to-head
AGNC
EFC
13.3%C+
Yield
11.6%C+
+84.7%A
Rev
+8.6%B
7.17D
D/E
9.29D
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
The companies
AGNCAGNC Investment Corp.
Why now
REIT - Mortgage · market cap $13.0b. 10% off the 52-week high of $12.19. Revenue growing +85% — in hypergrowth territory. 9 sell-side analysts publish a mean 1-yr target of $11.06 (implying +1% upside).
Moat
Net margin 94% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 20% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
D/E 7.17 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Dividend payout 72% of earnings on a 13.3% yield — distribution coverage is thin; one earnings stumble could force a dividend cut.
EFCEllington Financial Inc.
Why now
REIT - Mortgage · market cap $1.8b. 4% off the 52-week high of $14.12. 7 sell-side analysts rate this a Buy with a mean 1-yr target of $14.86 (implying +9% upside).
Moat
Net margin 52% is exceptional — pricing-power territory rare outside premium software, branded staples, and specialty pharma. ROE 12% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere.
Risk
D/E 9.29 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Dividend payout 98% of earnings on a 11.6% yield — distribution coverage is thin; one earnings stumble could force a dividend cut.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.